NEHA PATEL: Open Payments
NPI 1457335069 · HOUSTON, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,230 in 54 payments from 23 companies in 2025. Trend: 2023 $1,414 · 2024 $691 · 2025 $1,230
Food & beverage: $1,230
| Company | Payments | Amount |
|---|---|---|
| CeQur Corporation | 1 | $198 |
| Corcept Therapeutics | 10 | $184 |
| Bayer Healthcare Pharmaceuticals Inc. | 5 | $104 |
| Insulet Corporation | 4 | $88 |
| Radius Health, Inc. | 3 | $82 |
| Madrigal Pharmaceuticals | 3 | $76 |
| ABBVIE INC. | 3 | $59 |
| Tandem Diabetes Care, Inc. | 3 | $57 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 3 | $51 |
| Corium, LLC | 5 | $41 |
Products named: CeQur Simplicity, Korlym, Kerendia, Omnipod, Tymlos, REZDIFFRA, VRAYLAR, t:slim X2 Insulin Pump with Control-IQ.
Industry payments across TX — which companies pay providers there.
